Management of TB during pregnancy, especially in high-risk communities

References

• Lonnroth K, Raviglione M. Global epidemiology of tuberculosis: prospects for control. Semin. Respir. Crit. Care Med.29(5), 481–491 (2008).
   PubMed Web of Science ®Google Scholar
• WHO. Global Tuberculosis Control – Epidemiology, Strategy And Financing. WHO, Geneva, Switzerland (2009).
   Google Scholar
• Knight M, Kurinczuk JJ, Nelson-Piercy C, Spark P, Brocklhurst P; UKOSS. Tuberculosis in pregnancy in the UK. Br. J. Obstet. Gynaec.116(4), 585–588 (2009).
   Google Scholar
• Chowdhury NN. Overview of tuberculosis of the female genital tract. J. Indian Med. Assoc.94(9), 345–346, 361 (1996).
   PubMedGoogle Scholar
• Singh N, Sumana G, Mittal S. Genital tuberculosis: a leading cause for infertility in women seeking assisted conception in North India. Arch. Gynecol. Obstet.278(4), 325–327 (2008).
   PubMed Web of Science ®Google Scholar
• Nezar M, Goda H, El-Negery M, El-Saled M, Wahab AA, Badawy AM. Genital tract tuberculosis among infertile women: an old problem revisited. Arch. Gynecol. Obstet. DOI: 10.1007/s00404-009-1000-9 (2009) (Epub ahead of print).
   Google Scholar
• Jindal UN. An algorithmic approach to female genital tuberculosis causing fertility. Int. J. Tuberc. Lung Dis.10(9), 1045–1050 (2006).
   PubMed Web of Science ®Google Scholar
• Bolt HM. Rifampicin, a keystone inducer of drug metabolism: from Herbert Remmer’s pioneering ideas to modern concepts. Drug Metab. Rev.36, 497–509 (2004).
   PubMed Web of Science ®Google Scholar
• Llewelyn M, Cropley I, Wilkisnon RJ et al. Tuberculosis diagnosed during pregnancy: a prospective study from London. Thorax55, 129–132 (2000).
   PubMed Web of Science ®Google Scholar
• Story A, Murad S, Roberts W, Verheyen M, Hayward AC; London Nurses Tuberculosis Network. Tuberculosis in London; the importance of homelessness, problem drug use and prison. Thorax62(8), 667–671 (2007).
   PubMed Web of Science ®Google Scholar
• Storla DG, Yimer S, Bjune SJ. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health14, 8–15 (2008).
   Google Scholar
• Present PA, Comstock GW. Tuberculin testing in pregnancy. Am. Rev. Respir. Dis.112, 356–363 (1975).
   Google Scholar
• Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashota N, Oka M. Clinical evaluation of QuantiFERON TB-2G test for immuncomproised patients. Eur. Respir. J.30, 945–950 (2007).
   PubMed Web of Science ®Google Scholar
• Rangaka MX, Diwakar L, Seldon R et al. Clinical immunological and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. Clin. Infect. Dis.44(12), 1639–1646 (2007).
   PubMed Web of Science ®Google Scholar
• Cetinkaya E, Yildiz P, Altin S, Yilmaz V. Diagnostic value of transbronchial needle aspiration by Wang 22-gauge cytology needle in intrathoracic lymphadenopathy. Chest125(2), 527–531 (2004).
   PubMed Web of Science ®Google Scholar
• Yu YL, Chow WH, Humphries MJ, Wong RWS, Gabriel M. Cryptic miliary tuberculosis. Quart. J. Med.228, 421–428 (1986).
   Google Scholar
• Proudfoot AT, Akhtar AJ, Douglas AC, Hrone NW. Miliary tuberculosis in adults. BMJ2, 273–276 (1969).
   PubMedGoogle Scholar
• Khan M, Pillay T, Moodley JM, Connolly CA; Durban Perinatal TB HIV-1 Study Group. Maternal mortality associated with tuberculosis–HIV-1 co-infection in Durban, South Africa. AIDS15(14), 1857–1863 (2001).
   PubMed Web of Science ®Google Scholar
• Ragupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol. Today18, 478–482 (1997).
   PubMedGoogle Scholar
• Aris A, Lambert F, Besette P, Moutquin JM. Maternal circulating interferon-γ and interleukin-6 as biomarkers of Th1/Th2 immune status throughout pregnancy. J. Obstet. Gynaecol. Res.34, 7–11 (2008).
   PubMed Web of Science ®Google Scholar
• Halonen M, Lohman IC, Stern DA et al. Th1/Th2 patterns and balance of cytokine production in the parents and infants of a large birth cohort. J. Immunol.182, 3285–3293 (2009).
   PubMed Web of Science ®Google Scholar
• Mishan-Eisenberg G, Borovsky Z, Weber MC, Gazit R, Tykocinski ML, Rachmilewitz J. Differential regulation of Th1/Th2 cytokine responses by placental protein 14. J. Immunol.173, 5524–5530 (2004).
   PubMed Web of Science ®Google Scholar
• Guleria I, Khosroshahi A, Ansari MJ et al. A critical role for the programmed cell death ligand 1 in fetomaternal tolerance. J. Exp. Med.202, 231–237 (2005).
   PubMed Web of Science ®Google Scholar
• Reinhard G, Noll A, Shlesbusch H, Mallmann P, Ruecker AV. Shifts in the Th1/Th2 balance during human pregnancy correlate with apoptotic changes. Biochem. Biophys. Res. Comm.245, 933–938 (1998).
   PubMed Web of Science ®Google Scholar
• Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum. Reprod. Update1, 1–19 (2009).
   Google Scholar
• Lienhardt C, Azzurri A, Amedei A et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur. J. Immunol.32, 1605–1613 (2002).
   PubMed Web of Science ®Google Scholar
• Bjerkedal T, Bahna SL, Lehmann EH. Course and outcome of pregnancy in women with pulmonary tuberculosis. Scand. J. Respir. Dis.56, 245–250 (1975).
   PubMedGoogle Scholar
• Crampin AC, Glynn JR, Floyd S et al. Tuberculosis and gender: exploring the patterns in a case control study in Malawi. Int. J. Tuberc. Lung Dis.8, 194–203 (2004).
   PubMed Web of Science ®Google Scholar
• Datiko DG, Yassin MA, Chekol LT, Kabeto LE, Lindtjǿrn B. The rate of TB–HIV co-infection depends on the prevalence of HIV infection in the community. BMC Public Health30(8), 266 (2008).
   Google Scholar
• Gupta A, Nayak U, Ram M et al. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India 2002–2005. Clin. Infect. Dis.45, 241–248 (2007).
   PubMed Web of Science ®Google Scholar
• Panchabhai TS, Patil PD, Shah DR, Joshi AS. An autopsy study of maternal mortality: a tertiary healthcare perspective. J. Postgrad. Med.55, 8–11 (2009).
   PubMed Web of Science ®Google Scholar
• Pillay T, Khan M, Moodley J, Adhikari M, Coovadia H. Perinatal tuberculosis and HIV-1: considerations for resource-limited settings. Lancet Infect. Dis.4, 155–165 (2004).
   PubMed Web of Science ®Google Scholar
• Ahmed Y, Mwaba P, Chintu C et al. A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. Int. J. Tuberc. Lung Dis.3, 675–680 (1999).
   PubMed Web of Science ®Google Scholar
• Townsend CL, Willey BA, Cortina-Borja M, Peckham CS, Tookey PA. Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990–2007. AIDS23, 519–524 (2009).
   PubMed Web of Science ®Google Scholar
• Galli L, Puliti D, Chiappini E et al. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1? Clin. Infect. Dis.48, 1310–1317 (2009).
   PubMed Web of Science ®Google Scholar
• Zhou J, Elliott J, Li PC et al. Risk and prognostic significance of tuberculosis in patients from the TREAT Asia HIV Observational Database. BMC Infect. Dis.9(1), 46 (2009).
   PubMed Web of Science ®Google Scholar
• Brown ER, Otieno P, Mbori-Ngacha DA et al. Comparison of CD4 cell count, viral load and other markers for the prediction of mortality among HIV-1-infected Kenyan pregnant women. J. Infect. Dis.199, 1292–1300 (2009).
   PubMed Web of Science ®Google Scholar
• Golub JE, Pronyk P, Mohapi L et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS23(5), 631–636 (2009).
   PubMed Web of Science ®Google Scholar
• Cotton MF, Schaaf HS, Lottering G, Weber HL, Coetzee J, Nachman S; PACTG 1041 team. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int. J. Tuberc. Lung Dis.12, 225–227 (2008).
   PubMed Web of Science ®Google Scholar
• Snider DE Jr, Bloch AB. Congenital tuberculosis. Tubercle65, 81–81 (1984).
   PubMedGoogle Scholar
• Hesseling AC, Cotton MF, Jennings T et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin. Infect. Dis.48, 108–114 (2009).
   PubMed Web of Science ®Google Scholar
• Kali PB, Gray GE, Violari A et al. Combining PMTCT with active case-finding for tuberculosis. J. Acquir. Immune Defic. Syndr.42, 379–381 (2006).
   PubMed Web of Science ®Google Scholar
• Snider DE Jr, Layde PM, Johnson MW et al. Treatment of tuberculosis in pregnancy. Am. Rev. Respir. Dis.122, 65–79 (1980).
   PubMed Web of Science ®Google Scholar
• Eriksen NL, Helfgott AW. Cutaneous anergy in pregnant and nonpregnant women with human immunodeficiency virus. Infect. Dis. Obstet. Gynecol.6(1), 13–17 (1998).
   PubMedGoogle Scholar
• Nachega J, Coetzee J, Adendorff T et al. Tuberculosis active case-finding in a mother-to-child HIV transmission prevention program in Soweto, South Africa. AIDS17, 1398–1400 (2003).
   PubMed Web of Science ®Google Scholar
• Cruz CA, Caughey AB, Jasmer R. Postpartum follow-up of a positive purified protein derivative (PPD) among an indigent population. Am. J. Obstet. Gynecol.192(5), 1455–1457 (2005).
   PubMed Web of Science ®Google Scholar
• Schwartz N, Wagner SA, Keeler SM, Mierlak J, Seubert DE, Caughey AB. Universal tuberculosis screening in pregnancy. Am. J. Perinatol.26, 447–451 (2009).
   PubMed Web of Science ®Google Scholar
• Schulte JM, Bryan P, Dodds S, Potter M, Onorato IM, O’Sullivan MJ. Tuberculosis skin testing among HIV-infected pregnant women in Miami, 1995–1996. J. Perinatol.22, 159–162 (2002).
   PubMedGoogle Scholar
• Pepper T, Joseph P, Mwenya C et al. Normal chest radiography in pulmonary tuberculosis: implications for obtaining respiratory specimen cultures. Int. J. Tuberc. Lung Dis.12(4), 397–403 (2008).
   PubMed Web of Science ®Google Scholar
• Pai M, Zwerlin A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med.149, 177–184 (2008).
   PubMed Web of Science ®Google Scholar
• Griffiths C, Sturdy P, Brewin P et al. Educational outreach to promote screening for tuberculosis in primary care: a clustered randomised controlled trial. Lancet369, 1528–1534 (2007).
   PubMed Web of Science ®Google Scholar
• Petrou S, Henderson J, Roberts T, Martin M-A. Recent economic evaluations of antenatal screening: a systematic review and critique. J. Med. Screen.7, 59–73 (2000).
   PubMed Web of Science ®Google Scholar
• Jana N, Vasishta K, Jindal SK, Khunnu B, Ghosh K. Perinatal outcome in pregnancies complicated by pulmonary tuberculosis. Int. J. Gynecol. Obstet.44, 119–124 (1994).
   PubMed Web of Science ®Google Scholar
• Jana N, Vasishta K, Saha SC, Ghosh K. Obstetrical outcomes among women with extrapulmonary tuberculosis. N. Engl. J. Med.341, 645–649 (1999).
   PubMed Web of Science ®Google Scholar
• Bothamley G. Drug treatment for tuberculosis during pregnancy – safety considerations. Drug Safety24, 553–595 (2001).
   PubMed Web of Science ®Google Scholar
• Briggs GG, Freeman TK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk (8th Edition). Lippincott Williams & Wilkins, PA, USA (2008).
   Google Scholar
• Saukkonen JJ, Cohn DL, Jasmer RM et al. An official ATS statement: hepatotoxicity of antituberculous therapy. Am. J. Respir. Crit. Care Med.174, 935–952 (2006).
   PubMed Web of Science ®Google Scholar
• Inductivo-Yu I, Bonacini M. Highly active antiretroviral therapy-induced liver injury. Curr. Drug Safety3(1), 4–13 (2008).
   PubMedGoogle Scholar
• McKoy JM, Bennett CL, Scheetz MH et al. Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project. Drug Safety32(2), 147–158 (2009).
   PubMed Web of Science ®Google Scholar
• Moodie EE, Pant Pai N, Klein MB. Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts. PLoS One4(2), e4517 (2009).
   Google Scholar
• Orlovic D, Smego RA Jr. Paradoxical tuberculous reactions in HIV-infected patients. Int. J. Tuberc. Lung Dis.5(4), 370–375 (2001).
   PubMed Web of Science ®Google Scholar
• Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst. Rev. (2), CD001363 (1999).
   Google Scholar
• Rose DN. Benefits of screening for latent Mycobacterium tuberculosis infection. Arch. Intern. Med.160(10), 1513–1521 (2000).
   PubMedGoogle Scholar
• Cohn DL, O’Brien RJ, Geiter LJ et al. ATS/CDC – targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med.161(4), S221–S243 (2000).
   Google Scholar
• Boggess KA, Myers ER, Hamilton CD. Antepartum or postpartum isoniazid treatment of latent tuberculosis infection. Obstet. Gynecol.96, 757–762 (2000).
   PubMed Web of Science ®Google Scholar
• Woldehanna S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst. Rev. (4), CD000171 (2004).
   Google Scholar
• Brobac PC, del Castillo H, Sweetland et al. Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second line agents. Clin. Infect. Dis.40, 1689–1692 (2005).
   PubMed Web of Science ®Google Scholar
• Palacios E, Dalliman R, Munoz M et al. Drug-resistant tuberculosis and pregnancy: treatment outcomes of 38 cases in Lima, Peru. Clin. Infect. Dis.48, 1413–1419 (2009).
   PubMed Web of Science ®Google Scholar
• Lew W, Pai M, Oxlade O, Martin D, Menzies D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann. Intern. Med.149, 123–134 (2008).
   PubMed Web of Science ®Google Scholar
• Hwang SS, Kim HR, Kim HJ et al. Impact of resistance to first-line and injectable drugs on treatment outcome in MDR-TB. Eur. Respir. J.33, 581–585 (2009).
   PubMed Web of Science ®Google Scholar
• Shakibaei M, Baumann-Wilschke I, Rücker M, Stahlmann R. Ultrastructural characterization of murine limb buds after in vitro exposure to grepafloxacin and other fluoroquinolones. Arch. Toxicol.75(11–12), 725–733 (2002).
   PubMed Web of Science ®Google Scholar
• Polachek H, Holcberg G, Sapir G et al. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro. Eur. J. Obstet. Gynecol. Reprod. Biol.122(1), 61–65 (2005).
   PubMed Web of Science ®Google Scholar
• Drobniewski F, Eltringham I, Graham C, Magee JG, Smith EG, Watt B. A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK. Thorax57(9), 810–816 (2002).
   PubMed Web of Science ®Google Scholar
• Jeon DS, Kim DH, Kang HS et al. Survival and predictors of outcomes in non-HIV-infected patients with extensively drug-resistant tuberculosis. Int. J. Tuberc. Lung Dis.13(5), 594–600 (2009).
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Chronic Conditions. Tuberculosis. In: Clinical Diagnosis and Management of Tuberculosis and Measures for its Prevention and Control. Royal College of Physicians, London, UK (2006).
   Google Scholar
• Marais BJ. Tuberculosis in children. Pediatr. Pulmonol.43(4), 322–329 (2008).
   PubMed Web of Science ®Google Scholar
• World Health Organization Stop TB Partnership Childhood TB Subgroup. Chapter 4: childhood contact screening and management. Int. J. Tuberc. Lung Dis.11(1), 12–15 (2007).
   PubMed Web of Science ®Google Scholar
• Salisbury D, Ramsay M, Noakes K. Tuberculosis. In: Immunisation Against Infectious Disease. Department of Health, The Stationary Office, London, UK, 391–408 (2006).
   Google Scholar
• Colditz GA, Berkey CS, Mosteller F et al. The efficacy of bacillus Calmette–Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics96, 29–35 (1995).
   PubMed Web of Science ®Google Scholar
• Trunz BB, Fine PEM, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost–effectiveness. Lancet367, 1173–1180 (2006).
   PubMed Web of Science ®Google Scholar
• Hesseling AC, Cotton MF, Fordham von Reyn C, Graham SM, Gie RP, Hussey GD. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants. Int. J. Tuberc. Lung Dis.12(12), 1376–1379 (2008).
   PubMed Web of Science ®Google Scholar